Merck and Ridgeback Bio announced closing of collaboration and licensing transaction
On Jul. 1, 2020, Merck and and and Ridgeback Biotherapeutics announced that the U.S. Federal Trade Commission (FTC)…
On Jul. 1, 2020, Merck and and and Ridgeback Biotherapeutics announced that the U.S. Federal Trade Commission (FTC)…
On Jul. 1, 2020, T2 Biosystems announced completion of validation of its COVID-19 molecular diagnostic test, the T2SARS-CoV-2…
On Jul. 1, 2020, OPKO Health announced the results of COVID-19 molecular PCR and antibody tests for nursing…
On Jul. 1, 2020, Pfizer and BioNTech announced preliminary data from the most advanced of four investigational vaccine…
On Jul. 1, 2020, InBios announced that it had received Emergency Use Authorization (EUA) from the FDA for…
On Jun. 30, 2020, scientists from the Innovative Genomics Institute (IGI) at the University of California Berkeley announced…
On Jun. 30, 2020, AquaBounty Technologies announced it had successfully commenced the commercial-scale harvest of conventional Atlantic salmon…
On Jun. 30, 2020, Altimmune announced dosing of the first patient in the Company’s Phase 1b clinical trial…
On Jun. 29, 2020, Gilead Sciences announced that the Covid-19 drug Remdesivir will cost $3,120 for typical patient…
On Jun. 29, 2020, National Institutes of Health (NIH) researchers announced they had discovered that Mediterranean populations may…
On Jun. 29, 2020, the U.S. Dept. of Veterans Affairs (VA) announced it had launched a digital COVID-19…
On Jun. 29, 2020, the University of Oxford reported that potential COVID-19 hotspots can be identified using a…
On Jun. 29, 2020, Bharat Biotech announced it had successfully developed COVAXIN, India’s 1st vaccine candidate for COVID-19,…
On Jun. 29, 2020, JAMA reported that U.S. populationヨbased time series analysis conducted between March 9, 2020, and…
On Jun. 29, 2020, the Michael Smith Foundation for Health Research (MSFHR) COVID-19 Research Response Fund announced funding…
On Jun. 29, 2020, Altimmune announced it was awarded $4.7 million from the U.S. Army Medical Research &…
On Jun. 29, 2020, LabCorpᆴ announced that Covance, its drug development business, has deployed the Xcellerateᆴ COVID-19 solution…
On Jun. 29, 2020, Todos Medical announced that it had entered into a partnership with Meridian Health Services…
On Jun. 29, 2020, Luminex announced that the company had submitted an Emergency Use Authorization request to the…
On Jun. 26, 2020, more than 300 scientists and clinicians from the federal government, industry and academia published…
On Jun. 26, 2020, the COVID-19 Therapeutics Accelerator donors and partners announced the formation of the International COVID-19…
On Jun. 26, 2020, Vaxart announced that its oral COVID-19 vaccine had been selected to participate in a…
On Jun. 26, 2020, the California Institute for Regenerative Medicine (CIRM) awarded $750,000 to Dr. Xiaokui Zhang at…
On Jun. 25, 2020, the University of Alberta (U of A) announced a study that will analyze thousands…
On Jun. 25, 2020, Entos Pharmaceuticals announced the selection of two lead candidates for a pan-coronavirus Fusogenix DNA…
On Jun. 25, 2020, the World Health Organization (WHO) announced the end of the 10th outbreak of Ebola…
On Jun. 25, 2020, the U.S. Food and Drug Administration (FDA) approved Fintepla (fenfluramine), a Schedule IV controlled…
On Jun. 25, 2020, the Government of Canada announced the results of that funding competition: an investment of…
On Jun. 25, 2020, researchers at the University of British Columbia announced they had received a combined total…
On Jun. 25, 2020, Vaxart announced it had signed a Memorandum of Understanding with Attwill Medical Solutions Sterilflow,…